A Novel Risk-Scoring System to Identify the Potential Population Benefiting From Adjuvant Chemotherapy for Node-Negative TNBC Patients With Tumor Size Less Than 1 cm

BACKGROUND AND OBJECTIVES: Whether chemotherapy is needed in node-negative triple-negative breast cancer (TNBC) patients with tumor size less than 1 cm is still controversial. In our research, we constructed a novel risk-scoring system to identify the potential TNBC patients benefiting from adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yijun, Ma, Rulan, Chen, Heyan, Pu, Shengyu, Xie, Peiling, He, Jianjun, Zhang, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260021/
https://www.ncbi.nlm.nih.gov/pubmed/35814418
http://dx.doi.org/10.3389/fonc.2022.788883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260021/
https://www.ncbi.nlm.nih.gov/pubmed/35814418
http://dx.doi.org/10.3389/fonc.2022.788883

Ejemplares similares